1. Home
  2. CBRS vs DXCM Comparison

CBRS vs DXCM Comparison

Compare CBRS & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerebras Systems Inc. Class A Common Stock

CBRS

Cerebras Systems Inc. Class A Common Stock

HOLD

Current Price

$111.85

Market Cap

39.0B

Sector

Technology

ML Signal

HOLD

Logo DexCom Inc.

DXCM

DexCom Inc.

HOLD

Current Price

$78.40

Market Cap

34.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBRS
DXCM
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0B
34.4B
IPO Year
2024
2005

Fundamental Metrics

Financial Performance
Metric
CBRS
DXCM
Price
$111.85
$78.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
29
Target Price
★ $291.64
$96.46
AVG Volume (30 Days)
★ 7.5M
3.2M
Earning Date
11-12-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.18
EPS
N/A
★ 1.15
Revenue
N/A
N/A
Revenue This Year
$73.94
$12.17
Revenue Next Year
$232.73
$10.78
P/E Ratio
★ N/A
$67.62
Revenue Growth
N/A
N/A
52 Week Low
$107.90
$54.11
52 Week High
$265.63
$92.59

Technical Indicators

Market Signals
Indicator
CBRS
DXCM
Relative Strength Index (RSI) 25.42 33.28
Support Level N/A $62.02
Resistance Level $218.25 $79.03
Average True Range (ATR) 9.03 2.61
MACD -4.58 -0.75
Stochastic Oscillator 6.63 11.73

Price Performance

Historical Comparison
CBRS
DXCM

About CBRS Cerebras Systems Inc. Class A Common Stock

Cerebras Systems Inc is an AI company. It designs the world's fastest AI infrastructure for training and inference. The company builds the world's largest semiconductor as well as the AI systems to power, cool, and feed the processors data. It develops software to link these systems together into industry-leading supercomputers that are simple to use even for the most complicated AI work, using familiar ML frameworks like PyTorch. Customers use its supercomputers to train industry-leading models. The company uses these supercomputers to run inference at speeds unobtainable from alternative commercial technologies. It delivers these AI capabilities to its customers on-premise and via the cloud. The company generates the majority of its revenue from the USA.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Share on Social Networks: